Chicago 14th Annual Congress PME Symposia


Round out your CMHC educational experience by attending Professional Medical Education/Product Theater symposia focused on novel therapies. These non-certified activities are planned solely by the sponsoring organizations/companies. There are no additional fees to attend once you have registered for CMHC Annual and meals or refreshments may be provided. Register for CMHC Annual today and attend these activities.


PME Lunch Symposium · Thursday, October 10, 2019 · 12:00pm – 1:00pm

Reviewing A1C and Cardiovascular Safety Data in T2D Therapies

Faculty: Joshua M. Stolker, MD

An endocrinologist/diabetologist or a cardiologist discuss a multidisciplinary approach to the management of adults living with type 2 diabetes (T2D). The presenter will review the clinical trial program for two GLP-1 RA agents, as well as present the CVOT data.

Visit the Novo Nordisk booth for more information.

Financial support for this program is provided by Novo Nordisk.


PME Light Bites Symposium · Thursday, October 10, 2019 · 4:10pm – 5:10pm

TBD

Faculty: TBD

Sponsored by Amgen, Inc.


PME Light Bites Symposium · Thursday, October 10, 2019 · 5:20pm – 6:20pm

Expert Insights: Managing Cardiovascular Risk Based on a Landmark CV Outcomes Study

Faculty: George Grunberger, MD

Despite the benefits of LDL-C lowering, many patients on statin therapy with elevated triglycerides remain at risk for cardiovascular (CV) disease. In this presentation, Expert Insights: Managing Cardiovascular Risk Based on a Landmark CV Outcomes Study, the results from the CV outcomes trial, REDUCE-IT, will be reviewed. REDUCE-IT compared the number of major adverse CV events in 8179 patients with statin-controlled LDL-C, elevated triglycerides, and other CV risk factors including established CVD and diabetes.

Visit the Amarin Pharma, Inc. booth for more information.

Sponsored by Amarin Pharma, Inc.


PME Dinner Symposium · Thursday, October 10, 2019 · 6:30pm – 7:30pm

TBD

Faculty: TBD

Sponsored by Bayer.